Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A De Novo Frameshift Mutation in RPL5 with Classical Phenotype Abnormalities and Worsening Anemia Diagnosed in a Young Adult-A Case Report and Review of the Literature. | Medicina (Kaunas) | 2023 | 38004002 | PubTator, text mining | PubMed |
| Cytogenetics Is a Science, Not a Technique! Why Optical Genome Mapping Is So Important to Clinical Genetic Laboratories. | Cancers (Basel) | 2023 | 38001730 | PubTator, text mining | PubMed |
| Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas. | Cells | 2023 | 37998367 | PubTator, text mining | PubMed |
| Genomic profiling of subcutaneous patient-derived xenografts reveals immune constraints on tumor evolution in childhood solid cancer. | Nat Commun | 2023 | 37990009 | PubTator, text mining | PubMed |
| Inhibition of UFM1 expression suppresses cancer progression and is linked to the dismal prognosis and immune infiltration in oral squamous cell carcinoma. | Aging (Albany NY) | 2023 | 37980168 | PubTator, text mining | PubMed |
| Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation. | Invest Ophthalmol Vis Sci | 2023 | 37975847 | PubTator, text mining | PubMed |
| Clonal selection of hematopoietic stem cells after gene therapy for sickle cell disease. | Nat Med | 2023 | 37973947 | PubTator, text mining | PubMed |
| Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics. | JID Innov | 2023 | 37965425 | PubTator, text mining | PubMed |
| Desmoplastic small round cell tumor of the abdomen: A case report. | Medicine (Baltimore) | 2023 | 37960784 | PubTator, text mining | PubMed |
| Potential Associations between Vascular Biology and Hodgkin's Lymphoma: An Overview. | Cancers (Basel) | 2023 | 37958472 | PubTator, text mining | PubMed |
| Risk-directed therapy based on genetics and MRD improves the outcomes of AML1-ETO-positive AML patients, a multi-center prospective cohort study. | Blood Cancer J | 2023 | 37957175 | PubTator, text mining | PubMed |
| Clinically relevant core genes for hematologic malignancies in clinical NGS panel testing. | Blood Res | 2023 | 37926559 | PubTator, text mining | PubMed |
| MYC overexpression and SMARCA4 loss cooperate to drive medulloblastoma formation in mice. | Acta Neuropathol Commun | 2023 | 37919824 | PubTator, text mining | PubMed |
| Germline and somatic drivers in inherited hematologic malignancies. | Front Oncol | 2023 | 37904876 | PubTator, text mining | PubMed |
| Identification of key genes and validation of key gene aquaporin 1 on Wilms' tumor metastasis. | PeerJ | 2023 | 37904849 | PubTator, text mining | PubMed |
| Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan. | BMC Cancer | 2023 | 37904096 | PubTator, text mining | PubMed |
| First Female Patient with a Rare CIC-FOXO4-Translocated Sarcoma: A Case Report. | Case Rep Oncol | 2023 | 37900856 | PubTator, text mining | PubMed |
| Venetoclax-Azacitidine Bridging PTCy-haplo-PBSCT for Refractory Acute Myeloid Leukemia with IDH2 Mutations. | Case Rep Oncol | 2023 | 37900854 | PubTator, text mining | PubMed |
| Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing. | Nat Commun | 2023 | 37898613 | PubTator, text mining | PubMed |
| Alternative Genetic Diagnoses in Axenfeld-Rieger Syndrome Spectrum. | Genes (Basel) | 2023 | 37895297 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=19